30-day FRN

70829

Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel, TCC Precision
Medicine Face-to-Face Review Meeting.
Date: December 8–December 9, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Conference Center,
Marriott at Marinelli Road, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, National
Institute on Minority Health and Health
Disparities, National Institutes of Health,
6707 Democracy Blvd., Suite 800, Bethesda,
MD 20892, (301) 451–9536, mlaudesharp@
nih.gov.
Dated: November 9, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–28833 Filed 11–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Scientific
Information Reporting System (SIRS)
NIGMS
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on August 23,
2015, page 48549 and allowed 60-days
for public comment. One public

SUMMARY:

obtain supplemental information to the
annual Research Performance Progress
Report (RPPR) submitted by grantees of
the Institutional Development Award
(IDeA) Program and the Native
American Research Center for Health
(NARCH) Program. The SIRS will
collect program-specific data not
requested in the RPPR data collection
system. The IDeA Program is a
congressionally mandated, long-term
interventional program administered by
NIGMS aimed at developing and/or
enhancing the biomedical research
competitiveness of States and
Jurisdictions that lag in NIH funding.
The NARCH Program is an interagency
initiative that provides support to
American Indian and Alaska Native (AI/
AN) tribes and organizations for
conducting research in their
communities in order to address health
disparities, and to develop a cadre of
competitive AI/AN scientists and health
professionals. The data collected by
SIRS will provide valuable information
for the following purposes: (1)
Evaluation of progress by individual
grantees towards achieving granteedesignated and program-specified goals
and objectives, (2) evaluation of the
overall program for effectiveness,
efficiency, and impact in building
biomedical research capacity and
capability, and (3) analysis of outcome
measures to determine need for
refinements and/or adjustments of
different program features including but
not limited to initiatives and eligibility
criteria. Data collected from SIRS will
be used for various regular or ad hoc
reporting requests from interested
stakeholders that include members of
Congress, state and local officials, other
federal agencies, professional societies,
media, and other parties.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
613.

comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Institute of General Medical Sciences
(NIGMS), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments To OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Dr. W. Fred Taylor Ph.D.,
Branch Chief, Capacity-Building Branch
(CBB), Division of Training, Workforce
Development, and Diversity (TWD),
NIGMS, NIH, 45 Center Drive, Room
2AS43S, Bethesda MD 20892, or call
non-toll-free number (301) 435–0760 or
Email your request, including your
address to: [email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Scientific
Information Reporting System (SIRS),
0925-In Use Without OMB Control
Number, National Institute of General
Medical Sciences (NIGMS), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The SIRS is an online data
collection system whose purpose is to

ESTIMATED ANNUALIZED BURDEN HOURS

tkelley on DSK3SPTVN1PROD with NOTICES

Form name
SIRS
SIRS
SIRS
SIRS
SIRS
SIRS

.................
.................
.................
.................
.................
.................

VerDate Sep<11>2014

Number of
respondents

Respondents
Principal
Principal
Principal
Principal
Principal
Principal

Investigators,
Investigators,
Investigators,
Investigators,
Investigators,
Investigators,

19:47 Nov 13, 2015

Jkt 238001

COBRE Phase I ..........................
COBRE Phase II .........................
COBRE Phase III ........................
INBRE .........................................
IDeA–CTR ...................................
NARCH .......................................

PO 00000

Frm 00083

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

37
36
35
24
5
19

E:\FR\FM\16NON1.SGM

1
1
1
1
1
1

16NON1

Average
burden hours
per response
3.5
3.5
3.5
5.5
3.5
4.5

Total annual
burden hours
130
126
122
132
18
85

70830

Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices

Dated: November 10, 2015.
Tammy Dean-Maxwell,
Project Clearance Branch Liaison, NIGMS,
NIH.
[FR Doc. 2015–29085 Filed 11–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Opportunity for Public
Comment on the Dietary Supplement
Label Database
This document, originally
published on October 29, 2015 (80 FR
66549), has been amended to extend the
comment receipt date to December 31,
2015. The Office of Dietary
Supplements (ODS) at the National
Institutes of Health, in partnership with
the National Library of Medicine (NLM),
has developed a Dietary Supplement
Label Database (DSLD) that is compiling
all information from the labels of dietary
supplements marketed in the United
States. ODS welcomes comments about
features to add and functionality
improvements to make so the DSLD may
become a more useful tool to users.
A federal stakeholder panel for the
DSLD will consider all comments
received. The ODS requests input from
academic researchers, government
agencies, the dietary supplement
industry, and other interested parties,
including consumers. The DSLD can be
accessed online at http://
dsld.nlm.nih.gov.

SUMMARY:

To ensure full consideration, all
comments must be received by 11:59
p.m. EST, December 31, 2015.
ADDRESSES: Interested individuals and
organizations should submit their
responses to [email protected].
FOR FURTHER INFORMATION CONTACT:
Richard Bailen MBA, MHA, Office of
Dietary Supplements, National
Institutes of Health, 6100 Executive
Boulevard, Room 3B01, Bethesda, MD
20892–7517, Phone: 301–435–2920,
Fax: 301–480–1845, Email: ODS@
nih.gov.
DATES:

The DSLD
is a free resource that captures all
information present on dietary
supplement labels as provided by the
seller, including contents, ingredient
amounts, and any health-related
product statements, claims, and
cautions. It also provides a
downloadable photo of each label. Users
can search for and organize this
information in various ways. Research
scientists, for example, could use the

tkelley on DSK3SPTVN1PROD with NOTICES

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

19:47 Nov 13, 2015

Jkt 238001

DSLD to determine total nutrient intakes
from food and supplements in
populations they study. Health care
providers can learn the content of
products their patients are taking.
Consumers might use the DSLD to
search for and compare products of
interest.
The DSLD currently contains 50,000
labels, and it is expected to grow rapidly
over the next three years to include
most of the estimated 75,000+ dietary
supplement products sold to American
consumers. The DSLD is updated
regularly to include any formulation
changes and label information in a
product. It also includes the labels of
products that have been discontinued
and are no longer sold. More
information about the DSLD and its
current capabilities is available at http://
www.dsld.nlm.nih.gov and at Dwyer et
al., 2014.1
ODS would like to receive ideas and
suggestions for how the DSLD might
evolve. What features might be added,
improved, or enhanced—for example, in
capabilities related to search, sorting,
organization, and downloading of
information—that would make it a more
valuable tool for users?
Dated: November 5, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015–29177 Filed 11–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
1 Dwyer JT, Saldanha LG, Bailen RA, et al. A free
new dietary supplement label database for
registered dietitian nutritionists. J Acad Nutr Diet.
2014;114(10):1512–7.

PO 00000

Frm 00084

Fmt 4703

Sfmt 4703

Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Planning Grant (R34) and Implementation
Cooperative Agreement (U01).
Date: December 9, 2015.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3C100, 5601 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3E72A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5023,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 9, 2015.
Natasha Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–28835 Filed 11–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Development of Cripto-1
Point of Care (POC) Tests and Kits for
the Detection of Cancer
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:

This notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Cancer Institute,
National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive patent license to practice
the inventions embodied in the
following U.S. Patents and Patent
Applications to Beacon Biomedical, Inc.
(‘‘Beacon’’) located in Scottsdale, AZ,
USA. A notice was previously
published on December 6, 2013 in
Volume 78, Number 235 for a period of
thirty (30) days. Herein, the National
Cancer Institute, National Institutes of
Health, Department of Health and
Human Services, is proposing a
modification to the contents of the
previous notice regarding the following
intellectual property:

SUMMARY:

U.S. Provisional Patent Application No. 60/
264,643 filed January 26, 2001 entitled
‘‘Detection and Quantification of Cripto1’’ [HHS Ref. No. E–290–2000/0–US–01];

E:\FR\FM\16NON1.SGM

16NON1